SAREPTA THERAPEUTICS INC COM USD0.0001 financial statements, including revenue, expenses, profit, and loss

The total revenue of 0L35 for the last quarter is 413.46 M USD, and it's 4.20% higher compared to the previous quarter. The net income of Q1 24 is 36.12 M USD.